Acute Kidney Injury and Chronic Kidney Disease Management
Diagnosis and Initial Evaluation
- The American Diabetes Association recommends that an elevated serum creatinine indicates reduced kidney function and requires immediate calculation of estimated glomerular filtration rate (eGFR) to determine the severity and guide management, with the critical distinction being whether this represents acute kidney injury (≥50% increase over baseline within a short timeframe) versus chronic kidney disease (eGFR <60 mL/min/1.73 m² persisting >3 months) 1, 2, 3
- Acute Kidney Injury (AKI) is diagnosed by a ≥50% sustained increase in serum creatinine over a short period, or a rise of ≥0.3 mg/dL within 48 hours, according to the American College of Cardiology 1, 2, 4
- People with diabetes face higher AKI risk than those without diabetes, as stated by the American Diabetes Association 1, 2
- AKI carries increased risks of progressive chronic kidney disease and poor health outcomes, making timely identification critical, as recommended by the American Heart Association 1, 2
Chronic Kidney Disease (CKD) Diagnosis
- Creatinine levels ≥1.5 mg/dL in men or ≥1.3 mg/dL in women with corresponding eGFR <60 mL/min/1.73 m² define CKD stage 3 or higher, according to the National Kidney Foundation 3
- eGFR <30 mL/min/1.73 m² indicates stage 4 CKD, and <15 mL/min/1.73 m² indicates stage 5 (kidney failure), as defined by the National Kidney Foundation 3, 4
Management Strategy
- The American College of Cardiology recommends targeting blood pressure <130/80 mmHg in patients with CKD to reduce progression risk 3
- Use ACE inhibitors or ARBs in patients with UACR >300 mg/g and/or eGFR <60 mL/min/1.73 m², as recommended by the American Heart Association (strong recommendation) 3
- Do NOT discontinue these medications for creatinine increases <30% without volume depletion, as stated by the American Diabetes Association 1, 5, 2, 3